About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,809 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,809 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2081-2100 of 10,809 trials

CompletedTrial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19Blinded, multicenter, placebo-controlled, randomized clinical trial evaluating lopinavir/ritonavir vs placebo in early outpatient treatment of adults with COVID-19NCT04372628·Aurora, Colorado and 5 others Active not recruitingTesting the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in AdultsThis phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab.NCT04530565·Birmingham, Alabama and 210 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

CompletedSafety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Locally Advanced or Metastatic TumorsThis first-in-human open-label, multicenter, dose-escalation and expansion study is designed to evaluate the safety, tolerability, and PK of tiragolumab alone or in combination…NCT02794571·Scottsdale, Arizona and 27 others

RecruitingMetastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-TA multicenter, open-label, prospective study to investigate immune boost response changes in patients with metastatic castrate-resistant prostate cancer (mCRPC).NCT06134232·Tuscon, Arizona and 30 others

CompletedThe Plecanatide Chronic Idiopathic Constipation (CIC) StudyThis is a randomized, double-blind, placebo controlled, 12 week repeat oral dose, dose ranging study to determine the efficacy and safety of 3 doses of plecanatide compared to…NCT01429987·Mobile, Alabama and 120 others

CompletedStudy Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the PancreasA prospective, multicenter, open label, randomized phase III study to evaluate efficacy and safety of FFX versus CPI-613 + mFFX in patients with metastatic adenocarcinoma of the…NCT03504423·Gilbert, Arizona and 73 others

RecruitingA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureInternational, Multicenter, Double-Blind, Placebo-Controlled and Event-driven study to assess efficacy, safety and Tolerability of Baxdrostat in combination with Dapagliflozin on…NCT06742723·Fairhope, Alabama and 770 others

CompletedVinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the UrotheliumThe purpose of this clinical research study is to learn if vinflunine can shrink or slow the growth of the cancer or increase survival in patients with transitional cell carcinoma…NCT00101608·Beverly Hills, California and 74 others

CompletedShort-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV InfectionsCytomegalovirus (CMV) infection is known to cause hearing loss and mental retardation.NCT00466817·Birmingham, Alabama and 47 others

Active not recruitingPhase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System AtrophyThis is a Phase 3, multi-center, randomized withdrawal study to evaluate the efficacy and durability of ampreloxetine in participants with MSA and symptomatic nOH after 20 weeks…NCT05696717·Scottsdale, Arizona and 78 others

CompletedVisualization of the Colon Through Use of the Magnetic Flexible Endoscope (MFE)In this study, the investigators will evaluate the ability of the Magnetic Flexible Endoscope (MFE) to travel through the human colon.NCT05833789·Nashville, Tennessee

CompletedStudy to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm InfantsThe purpose of this study was to evaluate the efficacy, safety, pharmacokinetics (PK), and immunogenicity of suptavumab (REGN2222) in infants born no more than 35 weeks, 6 days…NCT02325791·Birmingham, Alabama and 204 others

CompletedMaribavir for Treatment of Resistant or Refractory CMV Infections in Transplant RecipientsThis study will assess safety, antiviral activity, and pharmacokinetics of different doses of maribavir administered orally for up to 24 weeks for treatment of CMV infections that…NCT01611974·Los Angeles, California and 31 others

CompletedTrial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With ConstipationThe objective of this trial is to determine the efficacy and safety of linaclotide administered to patients with irritable bowel syndrome with constipation (IBS-C).NCT00948818·Birmingham, Alabama and 117 others

CompletedLung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching BiomarkersThis phase II trial studies how well durvalumab works in treating patients with stage IV squamous cell lung cancer that has come back after previous treatment.NCT02766335·Birmingham, Alabama and 992 others

WithdrawnAssessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza InfectionThe purpose of this study is to evaluate the rate of decline in quantitative viral load measured in hospitalized patients with Influenza A infectionNCT01992276·Fresno, California and 67 others

Active not recruitingDose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid TumorsThe purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of escalating doses of RMC-6291 (KRAS G12C(ON) inhibitor) monotherapy in adult…NCT05462717·Springdale, Arkansas and 63 others

CompletedPhase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid TumorsCK-101 is a novel, potent, small molecule tyrosine kinase inhibitor (TKI) that selectively targets mutant forms of the epidermal growth factor receptor (EGFR) while sparing…NCT02926768·Sarasota, Florida and 19 others

CompletedEfficacy of Different Oral Rehydration Solutions on the Hydration Status of Healthy MalesDehydration lowers both physical and mental performance if it is severe enough.NCT05428774·Nashville, Tennessee

CompletedIntensive Viral Dynamics Substudy of A5248The HIV integrase inhibitor, raltegravir (RAL), which was recently approved by the FDA, has been shown in several trials to be highly effective.NCT00852618·Aurora, Colorado and 5 others

PreviousPage 105 of 541Next

Diabetes

in Nashville

Heart Diseasein Nashville